These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9211494)

  • 101. Pancreatic diabetes in Japan.
    Koizumi M; Yoshida Y; Abe N; Shimosegawa T; Toyota T
    Pancreas; 1998 Apr; 16(3):385-91. PubMed ID: 9548683
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Glucose Counter-regulation After Acute Pancreatitis.
    Bharmal SH; Pendharkar S; Singh RG; Cho J; Petrov MS
    Pancreas; 2019; 48(5):670-681. PubMed ID: 31091214
    [TBL] [Abstract][Full Text] [Related]  

  • 103. The Integrated Islet Distribution Program answers the call for improved human islet phenotyping and reporting of human islet characteristics in research articles.
    Brissova M; Niland JC; Cravens J; Olack B; Sowinski J; Evans-Molina C
    Diabetologia; 2019 Jul; 62(7):1312-1314. PubMed ID: 31089753
    [No Abstract]   [Full Text] [Related]  

  • 104. High prevalence of diabetes in patients with pancreatic cancer in central Anatolia, Turkey.
    Cetin M; Colak R; Bayram F; Altinbaş M; Unal A; Keleştimur F
    Diabetes Res Clin Pract; 2002 Nov; 58(2):97-100. PubMed ID: 12213350
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Computational prediction and experimental validation associating FABP-1 and pancreatic adenocarcinoma with diabetes.
    Sharaf RN; Butte AJ; Montgomery KD; Pai R; Dudley JT; Pasricha PJ
    BMC Gastroenterol; 2011 Jan; 11():5. PubMed ID: 21251264
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes.
    Wang H; Cao J; Su JB; Wang XQ; Wang X; Zhang DM; Wang XH
    Diabetol Metab Syndr; 2021 Jun; 13(1):70. PubMed ID: 34174950
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes.
    Niwano F; Hiromine Y; Noso S; Babaya N; Ito H; Yasutake S; Matsumoto I; Takeyama Y; Kawabata Y; Ikegami H
    J Diabetes Investig; 2018 Sep; 9(5):1084-1090. PubMed ID: 29288524
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Human pancreatic polypeptide.
    Floyd JC
    Clin Endocrinol Metab; 1979 Jul; 8(2):379-99. PubMed ID: 225071
    [No Abstract]   [Full Text] [Related]  

  • 109. Hyperglycemia predicts adverse prognosis in advanced pancreatic cancer patients.
    Zhu X; Xu H; Xiao Z; Liu H; Ni Q; Yu X; Luo G
    Endocrine; 2023 Feb; 79(2):296-303. PubMed ID: 36609907
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Diagnosis of pancreatic cancer. Alteration of glucose metabolism.
    Permert J; Larsson J; Ihse I; Pour PM
    Int J Pancreatol; 1991; 9():113-7. PubMed ID: 1744436
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Fasting blood glucose levels in patients with different types of diseases.
    Zhang Q; Zhao G; Yang N; Zhang L
    Prog Mol Biol Transl Sci; 2019; 162():277-292. PubMed ID: 30905457
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Insulin-like growth factor-I, interleukin-1 alpha and beta in pancreatic cancer: role in tumor invasiveness and associated diabetes.
    Basso D; Plebani M; Fogar P; Panozzo MP; Meggiato T; De Paoli M; Del Favero G
    Int J Clin Lab Res; 1995; 25(1):40-3. PubMed ID: 7787209
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Current aspects of aetiology and diagnosis in diabetes mellitus.
    Turtle JR
    Med J Aust; 1976 Sep; 2(12):458-60. PubMed ID: 792643
    [No Abstract]   [Full Text] [Related]  

  • 114. Importance of Intestinal Environment and Cellular Plasticity of Islets in the Development of Postpancreatectomy Diabetes.
    Fukuda T; Bouchi R; Takeuchi T; Amo-Shiinoki K; Kudo A; Tanaka S; Tanabe M; Akashi T; Hirayama K; Odamaki T; Igarashi M; Kimura I; Tanabe K; Tanizawa Y; Yamada T; Ogawa Y
    Diabetes Care; 2021 Apr; 44(4):1002-1011. PubMed ID: 33627367
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Impact of diabetes and hyperglycemia on survival in advanced breast cancer patients.
    Villarreal-Garza C; Shaw-Dulin R; Lara-Medina F; Bacon L; Rivera D; Urzua L; Aguila C; Ramirez-Morales R; Santamaria J; Bargallo E; Mohar A; Herrera LA
    Exp Diabetes Res; 2012; 2012():732027. PubMed ID: 22919369
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Diabetic Ferroptosis and Pancreatic Cancer: Foe or Friend?
    Li L; Yu XJ; Gao L; Cheng L; Sun B; Wang G
    Antioxid Redox Signal; 2022 Dec; 37(16-18):1206-1221. PubMed ID: 35996983
    [No Abstract]   [Full Text] [Related]  

  • 117. Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide.
    Basso D; Valerio A; Seraglia R; Mazza S; Piva MG; Greco E; Fogar P; Gallo N; Pedrazzoli S; Tiengo A; Plebani M
    Pancreas; 2002 Jan; 24(1):8-14. PubMed ID: 11741177
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pancreatic islet (of Langerhans) revisited.
    Mandarim-de-Lacerda CA
    Histol Histopathol; 2019 Sep; 34(9):985-993. PubMed ID: 31020988
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Recent Progress in the Use of Glucagon and Glucagon Receptor Antago-nists in the Treatment of Diabetes Mellitus.
    Lotfy M; Kalasz H; Szalai G; Singh J; Adeghate E
    Open Med Chem J; 2014; 8():28-35. PubMed ID: 25674162
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Prospective evaluation of some candidate tumor markers in the diagnosis of pancreatic cancer.
    Mackie CR; Moossa AR; Go VL; Noble G; Sizemore G; Cooper MJ; Wood RA; Hall AW; Waldmann T; Gelder F; Rubenstein AH
    Dig Dis Sci; 1980 Mar; 25(3):161-72. PubMed ID: 6989572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.